These results are consistent with the inhibitory effect of hyperglycemia on hepatic AMPK activity in vitro[6], [19], [20] and in STZ-induced type 1 diabetic mice in vivo[19]. The gene discussed is PRKAA2; the disease is Hyperglycemia.